Transferrin receptor 2 mitigates periodontitis‐driven alveolar bone loss
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Lennart Lösser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III & Center for Healthy Aging, Medical Faculty, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Alveolar Bone Loss, Periodontitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Periodontitis is associated with significant alveolar bone loss. Patients with iron overload suffer more frequently from periodontitis, however, the underlying mechanisms remain largely elusive. Here, we investigated the role of transferrin receptor 2 (Tfr2), one of the main regulators of iron homeostasis, in the pathogenesis of periodontitis and the dental phenotype under basal conditions in mice. As Tfr2 suppresses osteoclastogenesis, we hypothesized that deficiency of Tfr2 may exacerbate periodontitis‐induced bone loss. Mice lacking Tfr2 ( Tfr2 −/− ) and wild‐type ( Tfr2 +/+ ) littermates were challenged with experimental periodontitis. Mandibles and maxillae were collected for microcomputed tomography and histology analyses. Osteoclast cultures from Tfr2 +/+ and Tfr2 −/− mice were established and analyzed for differentiation efficiency, by performing messenger RNA expression and protein signaling pathways. After 8 days, Tfr2‐deficient mice revealed a more severe course of periodontitis paralleled by higher immune cell infiltration and a higher histological inflammation index than Tfr2 +/+ mice. Moreover, Tfr2‐ deficient mice lost more alveolar bone compared to Tfr2 +/+ littermates, an effect that was only partially iron‐dependent. Histological analysis revealed a higher number of osteoclasts in the alveolar bone of Tfr2 ‐deficient mice. In line, Tfr2 ‐deficient osteoclastic differentiation ex vivo was faster and more efficient as reflected by a higher number of osteoclasts, a higher expression of osteoclast markers, and an increased resorptive activity. Mechanistically, Tfr2 ‐deficient osteoclasts showed a higher p38‐MAPK signaling and inhibition of p38‐MAPK signaling in Tfr2 ‐deficient cells reverted osteoclast formation to Tfr2 +/+ levels. Taken together, our data indicate that Tfr2 modulates the inflammatory response in periodontitis thereby mitigating effects on alveolar bone loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine III & Center for Healthy Aging, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
- Department of Internal Medicine 3, University of Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Deutsches Zentrum für Immuntherapie (DZI), University of Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Policlinic of Operative Dentistry, Periodontology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
ORCID-Profile: Martina Rauner
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Lösser, L., Ledesma-Colunga, M. G., Andrés Sastre, E., Scholtysek, C., Hofbauer, L. C., Noack, B., Baschant, U., & Rauner, M. (2024). Transferrin receptor 2 mitigates periodontitis‐driven alveolar bone loss. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31172
Vancouver
Lösser L, Ledesma-Colunga MG, Andrés Sastre E, Scholtysek C, Hofbauer LC, Noack B, et al. Transferrin receptor 2 mitigates periodontitis‐driven alveolar bone loss. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31172
BibTeX
@article{Lsser2024,
author = {Lösser, Lennart and Ledesma-Colunga, Maria G and Andrés Sastre, Enrique and Scholtysek, Carina and Hofbauer, Lorenz C and Noack, Barbara and Baschant, Ulrike and Rauner, Martina},
title = {Transferrin receptor 2 mitigates periodontitis‐driven alveolar bone loss},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31172}
}
EUVIMED